During the past decade, Pfizer Local Country Office conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pfizer Local Country Office" are "Ulcerative Colitis" (2 trials), "Atopic Dermatitis" (1 trials), "COVID-19" (1 trials), "Chronic Heart Failure" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Pfizer Local Country Office" in a lesser frequency.

Most popular intervention types in "Pfizer Local Country Office" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Infliximab [infliximab biosimilar 3]" (3 trials), "BNT162b2" (1 trials), "CIBINQO" (1 trials), "Eplerenone" (1 trials) and "crizotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pfizer Local Country Office" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Pfizer Local Country Office". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Pfizer Local Country Office, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pfizer Local Country Office, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".